학술논문
TERT promoter mutations and the outcome of patients with advanced urothelial carcinoma treated by platinum-based chemotherapy or pembrolizumab.
Document Type
Article
Author
Source
In Pathology - Research and Practice January 2024 253
Subject
Language
ISSN
0344-0338